American Oncology Network expands access to advanced radioligand therapies

American Oncology Network (AONC) announced it is expanding access to cutting-edge radioligand therapies, providing more patients with targeted treatment options for certain metastatic and rare cancers. To date, more than 300 treatments have been delivered to nearly 70 patients across five AON partner practices, demonstrating both the growing demand for and success of these advanced therapies.